Research & Development
Boston Scientific receives FDA clearance for Asurys fluid management system
...
Aurinia Pharmaceuticals agrees to acquire Kezar Life Sciences
30 March 2026 - Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), a biopharmaceutical company focused on autoimmune diseases, announced on Monday that it has entered into a definitive merger agreement to acq...
Rocket Pharmaceuticals secures FDA approval for Kresladi gene therapy in severe LAD-I
27 March 2026 - Biotechnology company Rocket Pharmaceuticals Inc (NASDAQ:RCKT) announced on Friday that the US Food and Drug Administration (FDA) has granted accelerated approval for Kresladi (marnete...
Pharming receives positive CHMP opinion for Joenja marketing authorisation
...
Biocytogen partner NEOK Bio secures FDA IND clearance for cancer therapy candidate
27 March 2026 - Biotechnology company Biocytogen Pharmaceuticals (Beijing) Co Ltd (SSE:688796) (HKEX:02315) announced on Friday that its partner NEOK Bio Inc has received US Food and Drug Administrati...
Eisai and Nuvation Bio report taletrectinib MAA validated by European regulator
27 March 2026 - Japanese pharmaceutical company Eisai Co Ltd (TYO:4523) and US-based oncology company Nuvation Bio Inc (NYSE:NUVB) announced on Thursday that the European Medicines Agency (EMA) has va...